Hedge Fund - Baker Bros. Advisors
Rhythm Pharmaceuticals Inc. (RYTM)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $599,903,860 | 3.51% | 5,604,483 | $106.08 |
| 2 | 2025 - Q3 (2025-09-30) | $565,996,738 | 4.09% | 5,604,483 | $92.84 |
| 3 | 2025 - Q2 (2025-06-30) | $354,147,281 | 3.44% | 5,604,483 | $61.23 |
| 4 | 2025 - Q1 (2025-03-31) | $296,869,465 | 3.29% | 5,604,483 | $55.48 |
| 5 | 2024 - Q4 (2024-12-31) | $340,596,259 | 3.63% | 6,084,249 | $55.24 |
| 6 | 2024 - Q3 (2024-09-30) | $335,210,395 | 3.47% | 6,398,366 | $47.92 |
| 7 | 2024 - Q2 (2024-06-30) | $262,716,867 | 3.35% | 6,398,365 | $39.92 |
| 8 | 2024 - Q1 (2024-03-31) | $277,241,155 | 3.47% | 6,398,365 | $43.76 |
| 9 | 2023 - Q4 (2023-12-31) | $294,132,839 | 3.34% | 6,398,365 | $31.55 |
| 10 | 2023 - Q3 (2023-09-30) | $153,651,351 | 0.88% | 6,702,349 | $22.39 |
| 11 | 2023 - Q2 (2023-06-30) | $107,156,423 | 0.62% | 6,498,267 | $18.05 |
| 12 | 2023 - Q1 (2023-03-31) | $115,929,083 | 0.63% | 6,498,267 | $25.11 |
| 13 | 2022 - Q4 (2022-12-31) | $185,046,185 | 1.11% | 6,354,608 | $25.70 |
| 14 | 2022 - Q3 (2022-09-30) | $148,536,000 | 0.97% | 6,062,702 | $18.60 |
| 15 | 2022 - Q2 (2022-06-30) | $17,119,000 | 0.09% | 4,125,062 | $5.47 |
| 16 | 2022 - Q1 (2022-03-31) | $47,521,000 | 0.27% | 4,125,062 | $8.78 |
| 17 | 2021 - Q4 (2021-12-31) | $38,555,000 | 0.18% | 3,863,239 | $11.23 |
| 18 | 2021 - Q3 (2021-09-30) | $50,454,000 | 0.22% | 3,863,239 | $15.27 |
| 19 | 2021 - Q2 (2021-06-30) | $75,642,000 | 0.33% | 3,863,239 | $20.76 |
| 20 | 2021 - Q1 (2021-03-31) | $74,017,000 | 0.32% | 3,479,873 | $29.00 |
| 21 | 2020 - Q4 (2020-12-31) | $68,821,000 | 0.25% | 2,314,873 | $25.42 |
| 22 | 2020 - Q3 (2020-09-30) | $53,550,000 | 0.21% | 2,471,155 | $22.93 |
| 23 | 2020 - Q2 (2020-06-30) | $60,211,000 | 0.26% | 2,700,055 | $19.49 |
| 24 | 2020 - Q1 (2020-03-31) | $41,219,000 | 0.25% | 2,708,200 | $17.90 |
| 25 | 2019 - Q4 (2019-12-31) | $62,180,000 | 0.33% | 2,708,200 | $22.21 |
| 26 | 2019 - Q3 (2019-09-30) | $58,470,000 | 0.39% | 2,708,200 | $21.45 |
| 27 | 2019 - Q2 (2019-06-30) | $59,580,000 | 0.4% | 2,708,200 | $25.25 |
| 28 | 2019 - Q1 (2019-03-31) | $74,232,000 | 0.47% | 2,708,200 | $28.74 |
| 29 | 2018 - Q4 (2018-12-31) | $72,796,000 | 0.59% | 2,708,200 | $27.64 |
| 30 | 2018 - Q3 (2018-09-30) | $78,998,000 | 0.52% | 2,708,200 | $31.60 |
| 31 | 2018 - Q2 (2018-06-30) | $84,658,000 | 0.63% | 2,708,200 | $27.34 |
| 32 | 2018 - Q1 (2018-03-31) | $40,775,000 | 0.34% | 2,049,020 | $26.55 |
| 33 | 2017 - Q4 (2017-12-31) | $59,545,000 | 0.51% | 2,049,020 | $26.44 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center